# Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer

> **NCT02417662** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University College, London** · enrollment: 140 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** Radical Radiotherapy (Conventional RT and SABR)
- **OTHER:** Non-investigational SACT

## Key facts

- **NCT ID:** NCT02417662
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-08-19
- **Primary completion:** 2026-09
- **Final completion:** 2028-08
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02417662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02417662, "Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02417662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*